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ABSTRACT
Exosomesarenanosized(30–100nm)membranevesiclessecretedbymostcelltypes.
ExosomeshavebeenfoundtocontainvariousRNAspeciesincludingmiRNA,mRNA
andlongnon-proteincodingRNAs.Anumberofcancercellsproduceelevatedlevels
of exosomes. Because exosomes have been isolated from most body ﬂuids they may
provide a source for non-invasive cancer diagnostics. Transcriptome proﬁling that
usesdeep-sequencingtechnologies (RNA-Seq) oVersenormousamount ofdatathat
can be used for biomarkers discovery, however, in case of exosomes this approach
was applied only for the analysis of small RNAs. In this study, we utilized RNA-Seq
technologytoanalyzeRNAspresentinmicrovesiclessecretedbyhumanbreastcancer
celllines.
Exosomeswereisolatedfromthemediaconditionedbytwohumanbreastcancer
cell lines, MDA-MB-231 and MDA-MB-436. Exosomal RNA was proﬁled using the
Ion Torrent semiconductor chip-based technology. Exosomes were found to contain
various classes of RNA with the major class represented by fragmented ribosomal
RNA (rRNA), in particular 28S and 18S rRNA subunits. Analysis of exosomal RNA
content revealed that it reﬂects RNA content of the donor cells. Although exosomes
produced by the two cancer cell lines shared most of the RNA species, there was
a number of non-coding transcripts unique to MDA-MB-231 and MDA-MB-436
cells. This suggests that RNA analysis might distinguish exosomes produced by low
metastatic breast cancer cell line (MDA-MB-436) from that produced by highly
metastatic breast cancer cell line (MDA-MB-231). The analysis of gene ontologies
(GOs) associated with the most abundant transcripts present in exosomes revealed
signiﬁcant enrichment in genes encoding proteins involved in translation and rRNA
and ncRNA processing. These GO terms indicate most expressed genes for both,
cellularandexosomalRNA.
For the ﬁrst time, using RNA-seq, we examined the transcriptomes of exosomes
secreted by human breast cancer cells. We found that most abundant exosomal RNA
species are the fragments of 28S and 18S rRNA subunits. This limits the number
of reads from other RNAs. To increase the number of detectable transcripts and
improve the accuracy of their expression level the protocols allowing depletion of
fragmented rRNA should be utilized in the future RNA-seq analyses on exosomes.
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INTRODUCTION
Exosomes are nanosized membrane vesicles secreted by multiple cell types (Raposo &
Stoorvogel, 2013). The term “exosomes” was introduced in 1987 by Johnstone et al. (1987)
todescribethe“trash”vesiclesreleasedbydiVerentiatingreticulocytestodisposeunwanted
membrane proteins which are known to diminish during maturation of reticulocytes
to erythrocytes. Later exosomes have been implicated in more complex functions.
Raposo et al. (1996) have demonstrated that exosomes derived from B lymphocytes
activate T lymphocytes, suggesting a role for exosomes in antigen presentation in vivo.
In early studies, secreted microvesicles were named based on their cellular origins,
e.g., archaeosomes, argosomes, dexosomes, epididymosomes, prostasomes, oncosomes,
etc. (Raposo & Stoorvogel, 2013). More lately it became apparent that vesicles released
by the same cell type are heterogeneous and can be classiﬁed into at least three classes
based on their mode of biogenesis: (1) exosomes (30–130 nm in diameter), which
originate from multivesicular endosome (MVE); (2) microvesicles (100–1000 nm in
diameter), which are shed from the plasma membrane; (3) apoptotic bodies (1–4 m
in diameter), which are released from fragmented apoptotic cells during late stages of cell
death (Raposo & Stoorvogel, 2013). Various puriﬁcation procedures including sequential
centrifugationprotocolshavebeenproposedtoseparatethesevesiclesforfurtheranalysis.
Biochemical and proteomic analyses showed that exosomes contain speciﬁc protein set
reﬂecting their intracellular site of formation. Exosomes from diVerent cell types contain
endosome-associated proteins, e.g., tetraspanins (CD9, CD63, CD81, CD82), annexins,
Rab GTPases and ﬂotillin. Exosomes are also enriched in proteins involved in MVE
formation (Tsg101 and Alix), chaperones (Hsc73 and Hsc90) and cytoskeletal proteins
(Raimondo et al., 2011). Furthermore, exosomes contain proteins that are speciﬁc to the
cellsfromwhichtheyarederived(Choietal.,2012;Sandvig&Llorente,2012).
The research in the exosome ﬁeld has exploded rapidly after the discovery that these
microvesicles transport a large number of mRNA and miRNA (Valadi et al., 2007) and
that exosomal mRNAs could be translated into proteins by recipient cells (Ratajczak et al.,
2006; Valadi et al., 2007) and exosomal miRNAs are able to modulate gene expression in
recipient cells (Mittelbrunn et al., 2011). Interestingly, certain mRNAs and miRNAs were
identiﬁed as highly enriched in exosomes compared to that of the host cells indicating the
existence of selective sorting mechanism controlling incorporation of RNA into exosomes
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share speciﬁc sequence motifs that may potentially function as cis-acting elements for
targetingtoexosomes(Batagov,Kuznetsov&Kurochkin,2011).
Given the fact that exosomes carry complex biological information consisting of
proteins, lipids and RNAs, it is not surprising to ﬁnd that they have been implicated
in a variety of physiological and pathological conditions. Skokos et al. (2001) reported,
for example, that mast cells communicate with other cells of the immune system via
exosomespromotingmitogenicactivityinBandTlymphocytes.Anumberofstudieshave
demonstrated the role of exosomes in the development of the nervous system, synaptic
activity,neuronalregeneration,neuron-gliacommunicationandprotectionagainstinjury
(Lai & Breakeﬁeld, 2012). Furthermore, exosomes can be involved in the pathogenesis
of cancer and degenerative diseases. The fact that tumor cells release a large amount
of exosomes was initially demonstrated in ovarian cancer patients (Taylor, Homesley &
Doellgast, 1983). Exosomes were shown to be secreted by various tumor cells including
those derived from breast (King, Michael & Gleadle, 2012), colorectum (Silva et al., 2012),
brain (Graner et al., 2009), ovarian (Escrevente et al., 2011), prostate (Mitchell et al., 2009;
Nilssonetal.,2009),lung(Rabinowitsetal.,2009),andbladder(Weltonetal.,2010)cancer.
Asigniﬁcantlyhigheramountofexosomeswasfoundinplasmafromlungcancerpatients
compared to that of control individuals (Rabinowits et al., 2009). In colorectal cancer
patients, the amount of plasma circulating exosomes was constitutively higher than in
normalhealthyindividualsshowingthedirectcorrelationbetweenexosomesquantityand
malignancy(Silvaetal.,2012).
Manipulatingtumorcellstodecreasethereleaseofexosomesfollowedbytheirinjection
into immunocompetent mice led to a signiﬁcantly slower tumor growth compared to
that of unperturbed cells (Bobrie et al., 2012). It has been shown that exosomes which
are released from tumor cells are able to transfer a variety of molecules, including
cancer-speciﬁc, to other cells (Al-Nedawi, Meehan & Rak, 2009; Muralidharan-Chari et
al., 2009) to manipulate their environment, making it more favorable for tumor growth
and invasion. Glioblastoma-derived exosomes were found to be enriched in angiogenic
proteinsthatallowedthemtostimulateangiogenesisinendothelialcells(Skogetal.,2008).
Melanoma exosomes were shown to be instrumental in melanoma cell dissemination
via alterations in the angiogenic microenvironment. Hood et al. demonstrated that
metastatic factors responsible for the recruitment of melanoma cells to sentinel lymph
nodes are upregulated by melanoma exosomes themselves (Muralidharan-Chari et al.,
2009). Exosomes shed by human MDA-MB-231 breast carcinoma cells and U87 glioma
cellswerecapableofconferringthetransformedcharacteristicsofcancercellsontonormal
ﬁbroblasts and epithelial cells in part due to transferring tissue transglutaminase and
ﬁbronectin(Hood,San&Wickline,2011).
Because of their small size exosomes have an ability to penetrate intercellular contacts
to reach distant parts of the body with the help of the blood stream and other body ﬂuids.
Exosomes have been puriﬁed from human plasma, serum, bronchoalveolar ﬂuid, urine,
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2013).SinceexosomespossesscharacteristicproteinandRNAsignaturesoftheirhostcells,
analysis of exosomes in various body ﬂuids can be potentially utilized for non-invasive
diagnostics of cancer and other disorders. For example, aggressive human gliomas often
express a truncated and oncogenic form of the epidermal growth factor receptor, known
as EGFRvIII. The tumour-speciﬁc EGFRvIII was detected in serum microvesicles from
glioblastomapatients(Skogetal.,2008).HighstabilityofexosomalRNA(Skogetal.,2008;
Valadi et al., 2007) and ease of RNA detection by highly sensitive PCR makes detection
of exosomal RNA an attractive approach for the discovery of biomarkers. Indeed, mRNA
variantsandmiRNAscharacteristicofgliomascouldbedetectedinserummicrovesiclesof
glioblastoma patients (Skog et al., 2008). Expression proﬁles of serum microvesicle mRNA
by microarrays correctly separated individuals with glioblastoma from normal controls
(Noerholmetal.,2012).OfallRNAspecies,secretedmiRNAsweremostfrequentlyutilized
toward discovery of body ﬂuid-based biomarkers perhaps because miRNA expression
proﬁles are more informative than mRNA expression proﬁles in a number of diseases
(Grady&Tewari,2010).Inonestudy,analysisofplasma-andserum-derivedmicrovesicles
revealed 12 miRNAs diVerently expressed in prostate cancer patients compared to that
of healthy controls and 11 miRNAs upregulated in patients with metastases compared
to that of patients without metastases (Bryant et al., 2012). Interestingly, exosomes
released by breast cancer cells can be separated into diVerent classes depending on
their miRNAs content (Palma et al., 2012). Cells undergoing malignant transformation
producedexosomes containingselective miRNAs,whoserelease isincreased bymalignant
transformation, in contrast to cells that are not aVected by malignancy, whose exosomes
are packed with neutral miRNAs (Palma et al., 2012). The changes in exosomal miRNA
cargocouldprovideasignatureofthepresenceofmalignantcellsinthebody.
The majority of reported to date exosomal miRNA and mRNA proﬁles have been
generated using microarray approaches that suVer from several limitations. Microarrays
are biased for investigation of already discovered transcripts. In addition, there is
potential for cross-hybridization of RNAs that are highly related in sequence. Recently
developed next generation RNA sequencing technology (RNA-Seq) allows detection of
all RNA subtypes as well as of unannotated transcripts and has a high sensitivity toward
identiﬁcation of low-abundance RNAs. In case of exosomes, this approach was applied
onlyfor theanalysisof small(20–70nt) RNAs(Bellingham,Coleman &Hill,2012;Nolte-’t
Hoenetal.,2012).
In this study, we utilized the RNA-Seq approach to characterize the transcriptomes of
exosomessecretedbytwometastatichumanbreastcancercelllines.Wedescribeoptimized
computational workﬂow to analyze data generated by the Ion Torrent semiconductor
chip-based technology. We have identiﬁed and proﬁled RNA species present in exosomes
and host cells and discuss the utility of exosomal RNA as potential breast cancer-speciﬁc
biomarkers.
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Cell culture
Human breast cancer cell lines MDA-MB-436 (ATCC HTB-130TM) and MDA-MB-231
(ATCC HTB-26TM) were maintained at 37C in 5% CO2 and cultured in DMEM/F12
supplemented with 10% FBS. 48 h prior to exosome collection, cells were washed 3 times
withPBSandthemediumwaschangedtoserum-freeCCM5medium(ThermoScientiﬁc).
Exosome extraction
ExosomeswereisolatedandpuriﬁedfromthemediaofMDA-MB-436andMDA-MB-231
cell cultures using sequential centrifugation protocol. Brieﬂy, media was collected and
cellulardebriswasremovedbycentrifugationat3,000gfor10min.Thesupernatantwas
centrifugedat17,000gfor30minat4C.Thesupernatantwascollectedandcentrifuged
at 100,000g for 2 h to pellet exosomes. Exosomes pellets were then washed in ﬁltered
PBSandre-centrifugedat100,000g,thesupernatantwasremovedandtheﬁnalexosomal
pelletwasre-suspendedin100lPBS.
Transmission electron microscopy
A 50 l aliquot of exosomes was absorbed onto formvar carbon coated nickel grid for
1 h. The grid was positioned with the coating side facing the drop containing exosomes.
Then the grids were washed by sequentially positioning them on top of the droplets of
0.1 M sodium cacodylate, pH 7.6 and then ﬁxed in 2% paraformaldehyde and 2.5% glu-
taraldehydein0.1Msodiumcacodylate,pH7.6for10min.Thengridswerewashedagain
with 0.1 M sodium cacodylate, pH 7.6 and contrasted with 2% uranyl acetate in 0.1 M
sodium cacodylate, pH 7.6 for 15 min. After washing, the grids were incubated on top of
the drop of 0.13% methyl cellulose and negatively stained with 0.4% uranyl acetate for
10 min, air dried for 5 min and examined with a JEM-2200FS transmission electron
microscopeoperatedat100kV.
Nanoparticle tracking analysis
Supernatants containing vesicles were analyzed using a Nano-Sight LM10 instrument
equippedwitha405nmlaser(NanoSight,Amesbury,UK)at25C.Particlemovementwas
trackedbyNTAsoftware(version2.2,NanoSight)withlowrefractiveindexcorresponding
to cell-derived vesicles. Each track was then analyzed to get the mean, mode, and median
vesiclesizetogetherwiththevesicleconcentration(inmillions)foreachsize.
RNA isolation and analysis
Total RNA from exosomes (MDA-MB-436 and 231) and cultured cells (MDA-MB-231)
were isolated using the TRIzol reagent (Invitrogen). RNA quality and concentration were
assessedwiththeAgilent2100Bioanalyzer(ThermoScientiﬁc).CellularRNAwasanalyzed
usingRNA6000NanoKit(Agilent)andexosomalRNAwasanalyzedusingRNA6000Pico
kit(Agilent).
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Two hundreds ng of exosomal RNA and 3 g of total cell RNA was used as the starting
input for RNA-Seq library preparation. Sequencing was performed by AITbiotech
company (Singapore). Brieﬂy, total cell RNA was treated with RiboMinus Eukaryote kit
(Life Technologies) to remove rRNA. Then, exosomal and rRNA-depleted cellular RNAs
were fragmented using RNaseIII. Whole transcriptome library was constructed using the
Ion Total-RNA Seq Kit v2 (Life Technologies). Bar-coded libraries were quantiﬁed with
qRT–PCR. Each library template was clonally ampliﬁed on Ion Sphere Particles (Life
Technologies)usingIonOneTouch200TemplateKitv2(LifeTechnologies).Preparations
containing bar-coded libraries were loaded into 318 Chips and sequenced on the PGM
(LifeTechnologies).
cDNA synthesis and quantitative real-time PCR (RT-PCR)
Two-step RT-PCR was performed using the QuantiTect Reverse Transcription Kit
(QIAGEN GmbH, Hilden, Germany) according to manufacturer’s protocol. RT-PCR
was performed in a Rotor-Gene (Qiagen) using a SYBR Green PCR Master Mix. Primer
sequences are provided in Table S3. All reactions with template and without template
(negative controls) were run in duplicate and averaged. GAPDH was used as internal
control for mRNA. Ct value was detected for each gene meaning the cycle number
at which the amount of ampliﬁed gene of interest reaches a ﬁxed threshold. Relative
quantiﬁcation (fold change) was determined for the host cells and exosomal genes
expression and normalized to an endogenous control GAPDH relative to a calibrator as
2 11Ct (where1C D .Ct ofgeneofinterest)–(Ct ofendogenouscontrolgene(GAPDH)
and 11Ct D .1Ct of samples for gene of interest) – (1Ct of calibrator for the gene of
interest). Melting curves of each ampliﬁed products were analyzed to ensure uniform
ampliﬁcationofthePCRproducts.
Bioinformatics analysis
Raw reads ﬁltering
Raw reads generated by sequencing were subjected to several quality checks. The low
quality reads were removed by read trimming and read ﬁltering. Read trimming included
removalofadaptersequences,removalofthe30 endswithlowqualityscoresandtrimming
based on High-Residual Ionogram Values. Filtering of entire reads included removal of
short reads, adapter dimers, reads lacking sequencing key, reads with oV-scale signal and
polyclonalreads.Subsequentanalysiswasperformedwithhighqualityreadswhichpassed
throughthedescribedaboveﬁlteringsteps.
Reads mapping
Bowtie2version2.1.0wasusedtoalignallhigh-qualityreadstorRNAsequencesincluding
28S (NR 003287.2), 18S (NR 003286.2), 5S (NR 023379.1), and 5.8S (NR 003285.2)
rRNA. Reads mapped to rRNA sequences were ﬁltered out while the rest of the reads were
mapped to the human genome. The high-quality reads were mapped to hg19 build of
the human genome from University of California Santa Cruz (UCSC) genome browser
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etal.,2013;Langmead&Salzberg,2012)withtheirdefaultparametersinend-to-endmode
(-b2-sensitive) and deﬁning splice-junctions based on known splice-junctions (-G). To
classify the reads into known and unknown genes, the BAM ﬁle generated by Tophat2
was intersected to known gene (RefGene and GENCODE built V14 from UCSC database)
using BEDtools (Quinlan & Hall, 2010) and was used to count the number of reads by
SAMtools(Lietal.,2009).
Post-processing of the aligned reads
The mapped reads were further manipulated by removing the reads that mapped to
multiplelocations.Inparticular,theshortalignedreadswiththelengthof<20nucleotides
were eliminated to avoid the alignment errors such as mapping to multiple genomic
locations. Further ﬁltering included the removal of the low quality reads which fall
below the mapping quality score of 10 (-q 10) using SAMtools. For the coverage search,
the BAM ﬁle generated by Tophat2 was converted to BED format with option (-split)
using BEDtools. The BED ﬁle was converted again to BAM format using BEDtools.
We then developed python script (using pysam as part of the scripts) to calculate the
number of reads and read coverage in exons and protein-coding sequence (CDS) regions
consecutively.
RNA abundance calculation
RNA abundance was estimated with the help of Partek Genomics Suite software (Partek
Inc., St. Lous, MO) using Reference Sequence Gene (RefSeq Gene) and GENCODE
annotationbuiltversion14ofthosenotoverlappedwithRefSeqGenefromUCSCgenome
browser. The Expectation-Maximization (E/M) Algorithm (Xing et al., 2006) was used to
estimate the most likely relative expression levels of each gene isoform. Partek’s algorithm
was used to quantify the gene isoform expression level as reads per kilo base per million
mappedreads(RPKM).
Functional analysis of genes
Database for Annotation, Visualization, and Integrated Discovery (DAVID) (version 6.7)
was used to identify gene functional annotation terms that are signiﬁcantly enriched in
particular gene lists with the whole Human genes as the background (Huang, Sherman
& Lempicki, 2009). A list of gene symbols was generated for each dataset and was used
as input into DAVID. DAVID calculates a modiﬁed Fishers Exact p-value to demonstrate
Gene ontology (GO) and KEGG molecular pathway enrichment, where p-values less than
0.05 after Benjamini multiple test correction are considered to be strongly enriched in the
annotationcategory.Wealsousedacountthresholdof5andthedefaultvalueof0.1forthe
EASE (enrichment) score settings. We used more speciﬁc GO term categories provided by
DAVID,calledGOFAT,tominimizetheredundancyofgeneralGOtermsintheanalysisto
increasethespeciﬁcityoftheterms.
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 7/24Figure1 Analysisofexosomesproducedbybreastcancercelllines,MDA-MB-436andMDA-MB-231,
withNanosightLM10-HSinstrument.
RESULTS
Characterization of exosomes released by breast cancer cells
Exosomes were isolated from two breast cancer cell lines, MDA-MB-436 and MDA-MB-
231 using classical ultracentrifugation protocol. The size distribution and amount of
exosomes were analyzed using NanoSight LM10 nanoparticle tracking analysis (NTA).
NTA showed that MDA-MB-231 cells released 4  106 vesicles per cm2 of growth area
per 48 h that were predominantly 115 nm in size. MDA-MB-436 cells released 1:04107
vesicles per cm2 of growth area per 48 h that were predominantly 91 nm in size (Fig. 1).
The size of exosomes released from both cell lines ranged from 70 nm to 300 nm. An
examination of the puriﬁed vesicles using transmission electron microscopy revealed that
theyhadthesize(50–100nm)andmorphology(Fig.2)typicalofthatofexosomes.
Characterization of exosomal RNA
RNA was isolated from exosomes released by both breast cancer cell lines. Total RNA
was also extracted from MDA-MB-231 cell line as a control host cell line that produced
exosomes. Bioanalyzer data revealed that exosomes contain a broad range of RNA sizes
(30–500nt)andhaveverysmallamountofintactrRNA(5.2%inMDA-MB-231exosomes
and 5.6% in MDA-MB-436 exosomes) (Fig. 3) consistent with previous reports on
exosomalRNA(Rabinowitsetal.,2009;Valadietal.,2007).
Exosomal RNA deep sequencing using Ion Torrent technology
We utilized the Ion Torrent sequencing technology to proﬁle exosomal RNA produced by
MDA-MB-436 and MDA-MB-231 cell lines, as well as RNA obtained from host cell line
MDA-MB-231. Based on RNA quality assessment using Bioanalyzer proﬁling (Fig. 3) we
performedrRNAdepletionforcellularRNAbutnotforexosomalRNA.
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 8/24Figure2 TEMimageoftheexosomesproducesbyMDA-MB-436cellline.Electronmicroscopyallowed
visualizing membrane-bound nanovesicles sized 100 nm. White arrowheads pointing to the exosomes.
Scale bar D 100 nm.
Identiﬁcation of appropriate alignment tool for efﬁcient capture of
splice-junction reads produced by the Ion Torrent technology
RNA-Seq computational analysis workﬂow is presented in Fig. 4. The single-end RNA
reads generated from sequencing of the exosomal and host cell libraries were trimmed
to remove adapter sequences and then ﬁltered. After ﬁltering out low-quality reads, the
high-quality reads had a varying length ranging from 6 bp to >300 bp. These preceded
high-qualityreadswereconsideredforfurtheranalysis.ThetotalamountofreadsforRNA
fromMDA-MB-231cellswasabout4.8M.RNA-Seqresultedin3.5Mand3.2Mreads
for RNA from MDA-MB-436 and MDA-MB-231 cells derived exosomes, respectively.
At ﬁrst, the reads were aligned to rRNA sequences including 28S, 18S, 5S, and 5.8S
rRNA (see Methods). 24% of the reads in cellular and more than 80% of the reads of
both exosome samples were mapped to rRNA sequences (Fig. S2). The rest of the reads
were mapped to the human genome (UCSC; hg19 built) with the help of TMAP aligner
program in accordance with the Ion Torrent recommended pipeline (Technologies) (data
not shown). However, the use of TMAP resulted in misalignment of the splice-junction
reads or reads containing multiple exons to the genome (Fig. S1). Therefore, we used
alternative aligner Tophat 2.0.6 along with the Bowtie 2.0.5 for the read mapping.The
mapped results are shown in Fig. S2. In total, this alignment produced more than 4.3 M
(90%) reads of MDA-MB-231 cellular RNA that could be mapped to rRNA sequences
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 9/24Figure 3 Analysis of RNA from cells and exosomes by Bioanalyzer. Exosomal and total cell RNA was
analyzed with PicoChip and NanoChip, respectively.
andthehumangenome.FortheMDA-MB-231andMDA-MB-436cell-derivedexosomes,
these alignments resulted in 2.8 M (90%) and 3.2 M (91%) of mapped reads,
respectively(Fig.S2).Morethan80%ofmappedreadsfromexosomalsampleswerefound
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 10/24Figure 4 Flowchart of RNA-seq data analysis. The raw reads are exposed to pre-alignment quality
checks including the removal of adaptor sequences and low quality reads. The high quality reads are then
mapped to rRNA sequences using Bowtie2 version 2.1.0. The non-mapped rRNA reads were mapped to
human genome hg19 build of the human genome using TopHat version 2.0.6 with the aligner Bowtie
2.0.5. After mapping, low mapping quality reads less than 10; short reads with length less than 20 base
pairs and multi- reads were removed. Estimation of read counts and read coverage on mapped reads
where over 90% of exon (non-coding) and CDs (for coding) in transcript isoforms of RefGene and/
or GENCODE v14 gene models. The EM algorithm along with GENCODE v14 annotations was used to
estimatethereadcountandreadsperkilobasepermillionmappedreads(RPKM)onmappedtranscripts.
tobemappedtorRNAsequences.WefurtherinvestigatedthereadsofbothexosomalRNA
samples,whichmappedtorRNAsequences.Thesereadswerecountedandplottedasread
density over each rRNA sequence (shown in Fig. S3A). The mapped reads covered entire
lengthofallrRNAsequences.Themajorfractionsofmappedreadswere28Sand18SrRNA
(Fig.S3B).
Reads mapped to multiple locations in the genome have been eliminated to obtain
uniquely mapped reads. Subsequent downstream analysis was performed with the high
quality reads which had the read length greater than 20 bps and mapping quality score of
above 10 (see Methods). As a result, about 81, 76, and 70% out of all mapped reads were
considered as high quality mapped reads for MDA-MB-231 and MDA-MB-436 exosomal
RNA,andMDA-MB-231cellularRNA,respectively.
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mapped to rRNA sequences (Fig. 5) and 2% of the reads were mapped to known genes
(RefSeqand/orGENCODEgenemodels).Atthesametime,fortheMDA-MB-231cellular
RNA, for which rRNA depletion step was performed, the majority of the reads (58%)
was mapped to known genes (Fig. 5). To increase the number of reads for other RNAs
we attempted to deplete rRNA with the RiboMinusTMEukaryote Kit recommended by
Ion Total RNA-Seq Kit protocol. As expected, this protocol eYciently pulled down rRNA
from cellular RNA (>60%) but had little eVect on removal of rRNA from exosomal RNA
(Fig.S4).ThefailuretodepleteexosomalfragmentedrRNAcanbeexplainedbythedesign
of the RiboMinusTMProbe. It consists of 2 probes each for 5S, 5.8S, 18S and 28S RNA.
Becausetheprobesizeis22–25nucleotides,manyfragmentsofrRNAarenottargeted.
Content of cellular and exosomal transcriptomes
In total, 16,086 transcripts (11,657 genes) were detected with a normalized RPKM
value of greater than 1.0 at least in one sample. We used Integrative Genomics Viewer
(IGV) version 2.1.21 (Thorvaldsdottir, Robinson & Mesirov, 2013) to visualize mapped
reads and to check the coverage across human transcriptome. We observed frequently
misannotated transcripts in exosome samples with high RPKM value in those cases when
only small parts of the transcripts were covered by the reads (Fig. 6). This was the eVect
of low depth sequencing caused by the presence of a large amount of reads representing
rRNA. Therefore, we implemented more stringent criteria to obtain full-length expressed
genes by ﬁltering genes based on the RNA reads coverage. Reads which cover over 90%
of protein-coding sequence (CDS) of protein-coding genes and over 90% of exons in
non-codingsequenceofnon-codinggeneswereconsideredforfurtheranalysis.Toidentify
protein-coding genes in exosomal samples, the mapped reads of exosomal RNA were
pooled with estimated CDS coverage of >90% for both exosomal reads. The pooled
mappedreadswereusedtocalculateCDSineachexosomalsampleas>50%ofcoverage.
Using these criteria, we obtained lower number of annotated transcripts (6,187
transcripts or 3,437 genes) compared to that when RPKM values were considered (Fig. S5
and Table S1). As a result, some transcripts showed high coverage with CDSs criteria (for
example, ATPIF1) in exosomal RNA from MDA-MB-231 cells, even when the number of
readswassmall(lessthan5)(Fig.6B).Suchgeneswerealsotakenintoconsiderationinour
analysis. In total, 5821 (3115 genes) and 187 (115 genes) protein-coding transcripts were
detected based on the RNA reads coverage in cellular and exosomal samples, respectively.
Fornon-codinggenes,360(317genes)and131(131genes)transcriptsweredetectedbased
on the RNA reads coverage for cellular and exosomal samples, respectively. Analysis of
these transcripts revealed that they represented 90.8% of protein-coding genes and 9.2%
ofnon-codinggenesforhostcellsample;whileexosomalRNAsamplesrepresented50.4%
and49.6%ofprotein-codingand47.6%and52.4%ofnon-codinggenesinMDA-MB-231
and MDA-MB-436 cells derived exosomes, respectively (Table 1). We found that 98.3% of
protein-coding and 97.7% of non-coding exosomal transcripts were present in host cells
(Fig.7).
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 12/24Figure 5 Distribution of uniquely mapped RNA-seq reads among transcriptome. Reads which over-
lappedwithannotatedgenemodels(RefSeqand/orGENCODE)aretermedas“knowngenes”.Readsthat
placed outside of annotated gene models are termed as “unknown”. Reads which are mapped to rRNA
sequences including 5S, 5.8S, 18S, and 28S rRNA are named as “rRNA”.
Table 1 Amount of genes in cellular and exosomal RNA based on 90% coverage over protein-coding
sequence of genes and exons of non-coding genes. Note the large proportion of non-coding transcripts
in exosomal RNA.
Transcripttype MDA-MB-231
cellular
genes(%)
MDA-MB-231
exosomal
genes(%)
MDA-MB-436
exosomal
genes(%)
Protein-coding 90.8 50.4 47.6
Non-coding 9.2 49.6 52.4
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 13/24Figure 6 Example of low coverage transcript but very high RPKM in AURKAIP1 and ATPIF1
genes. (A) AURKAIP1 gene from chromosome position chr1:1,309,009–1,310,847 is shown using In-
tegrative Genomic Viewer. Among the three variants, (continued on next page...)
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the maximum value of protein-coding sequence (CDS) coverage, read count and RPKM is shown in the
right panel of read mapping. Both the exosomes shows very low coverage (7–22%) with read counts of 4,
whereas the RPKM value is 65.44 and 80.78 RPKM for exosomes of MDA-MB-231 and MDA-MB-436,
respectively. (B) ATPIF1 gene from chromosome position chr1:28,562,494–28,564,655 is visualized. The
MDA-MB-231 exosomes exhibit high CDS coverage (91%) with an exon count of 4.
Figure 7 Venn diagram presents overlap among protein-coding and non-coding gene symbols in
exosomesandcells. Almost all the genes in both exosomal RNA are the subset of cellular genes.
Exosomes are enriched in mRNAs functioning in protein transla-
tion and rRNA processing
WeperformedGeneOntology(GO)enrichmentanalysisusingtheDAVIDbioinformatics
resource, which employs a Fisher’s Exact Test with Benjamini–Hochberg correction. A
total of 377 enriched GO categories were derived using a P-value cut-oV of p < 0:05 for
3115 host MDA-MB-231 cellular genes: 286 Biological Process (BP) categories and 91
Molecular Function (MF) categories (Table S2). In total, 18 GO categories including 11
BP and 7 MF were derived from 115 exosomal genes from both cell lines. Figure 8 shows
top20BPcategoriesofthehostcellulargeneswhichincludetranslationprocess,cellcycle,
RNA processing, etc. (Fig. 8A and Table S2B). At the same time exosomal genes revealed
biological processes in translation, ribosome biogenesis, rRNA and ncRNA processing
GO categories (Fig. 8B and Table S2C). Since the major fraction of exosomal samples
were rRNA species, signiﬁcantly lower number of mRNA could be detected in exosomal
samples.Wehypothesizedthatthegenesdetectedfromexosomalsamplesshouldbehighly
expressedinthecells.Totestthehypothesis,weperformedGOenrichmentanalysisfor115
topexpressedgenesfromMDA-MB-231cellularsample.Thetop10GOterms(Fig.8Cand
Table S2D) of these top expressed genes are the same as in exosomal fraction (Fig. 8B and
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 15/24Figure 8 Gene Ontology (GO) enrichment analysis of genes detected in cellular and exosomal RNA
from breast cancer cell lines. The signiﬁcant GO terms was deﬁned as described in Materials and
Methods. (A) Top 20 signiﬁcant GO terms found in MDA-MB-231 cellular genes (3115 genes). (B)
Signiﬁcant GO terms found in exosomal genes from both cell-lines (MDA-MB-231 and MDA-MB-436).
(C) Top 20 signiﬁcant GO terms found in the most expressed 115 genes from MDA-MB-231 cellular
genes. The asterisks (*) indicate GO terms that present in exosomal genes.
Table S2C). We further created box plot of 115 exosomal genes in MDA-MB-231 cellular
sampleusingexpressionvalues(RPKM)(Fig.9).Thesedataclearlyshowedthatexosomes
areenrichedingeneswhicharehighlyexpressedinthehostcells.
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 16/24Figure 9 Expressed genes in exosomes found to be highly expressed in the host cells. The box plot
indicates expression level of all genes in cellular samples as compared to that of genes which were found
to be express in exosomes. Wilcoxon rank sum test represents signiﬁcant diVerence in expression level of
the two sets.
Non-coding transcripts could be classiﬁed into 13 categories (see Table 2). Both
exosomalandcellularsamplescontainedsmallnucleolarRNA(snoRNA)asmajorspecies.
The second most abundant class of non-coding transcripts according to GENCODE
annotation was “non-coding RNA” in cellular sample and small nuclear RNA (snRNA)
in exosomal samples. Overall, the top ﬁve RNA categories represented about 90% of all
noncodinggenesinbothexosomalandcellularRNA.
Validation analysis of RNA-seq data by qRT-PCR
Based on RNA-Seq data we evaluated presence and enrichment of several mRNA
transcriptsinexosomalRNA-RAB13,RPPH1,EEF1A1,FTH1,FTLandRPL28.qRT-PCR
analysis showed presence of all selected transcripts in exosomal samples (Fig. 10A).
Figure 10B demonstrates that the fold-change of qRT-PCR results are consistent with
thefold-changeofRNA-seqdata.
DISCUSSION
Until recently, the changes in gene expression during various biological processes
have been analyzed using microarray approaches that focus largely on the behavior of
protein-codingtranscripts.Becausemicroarraysarebasedonhybridization,theyhavehigh
background owing to cross-hybridization, they have a limited dynamic range of detection
and they rely upon known structures of genes. Development of RNA-Seq technology
permitted comprehensive analysis of whole transcriptomes with the single nucleotide
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 17/24Table 2 Amount of non-coding gene symbol in cellular and exosomal RNA based on 90% coverage
over exons of non-coding transcripts. In exosomes, the top 5 non-coding gene types including small
nucleolar RNA, small nuclear RNA, Mt tRNA, microRNA, and non-coding RNA represents about 90%
of non-coding genes in both exosome samples.
Genetype MDA-MB-231
cellular
(genesymbols)
MDA-MB-231
exosomal
(genesymbols)
MDA-MB-436
exosomal
(genesymbols)
small nucleolar RNA 214 83 51
small nuclear RNA 23 11 10
Mt tRNA 13 7 4
microRNA 34 6 2
non-coding RNA 42 1 0
guide RNA 20 0 1
vault RNA 3 0 3
rRNA 1 1 2
RNase MRP RNA 1 1 1
RNase P RNA 1 1 1
Mt rRNA 1 1 0
lincRNA 1 0 0
telomerase RNA 1 0 0
resolution allowing quantiﬁcation of most RNA molecules expressed in the cell or tissue
(Mortazavi et al., 2008). In this study, we used the Ion Torrent platform to interrogate
transcriptomes of exosomes released from two metastatic breast cancer cell lines. At the
time of conducting our analysis this technology produced relatively low number of reads,
yet we selected it as it provided the longest reads than any other sequencing platform.
This feature of the Ion Torrent technology was essential as we dealt with RNA isolated
from exosomeswhose natureand composition arestill not wellestablished. RNA-seqdata
analysisiscomplicatedbytheintricacyofdealingwithlargedatasets,readsqualitycontrol,
alignment procedure etc. DiVerent workﬂows and several algorithms have been proposed
to map reads to the reference genome and to perform data analysis (Chen, Wang & Shi,
2011;Mortazavietal.,2008).ComparisonofexpressionlevelsacrossdiVerentsamplesand
experiments is often diYcult and requires complicated normalization methods and these
arestillunderactivedevelopment.Thesituationisevenmorecomplexincaseofexosomal
transcriptomes that diVer signiﬁcantly from cellular transcriptomes.To address this issue,
we developed in this study customized bioinformatics workﬂow and demonstrated its
utilityforanalysisofexosomalRNA.BecausetheIonTorrentplatformproducesreadswith
diVerent length the dedicated algorithm for their alignment to the genome called TMAP
was recommended. We found out, however, that this tool does not allow satisfactory
mapping of reads that contain splice-junctions or span introns. Therefore, we choose
alternative aligning tool TopHat2 (with Bowtie2) which could handle reads of varying
lengthandidentifysplice-junctionsbasedonknownsplice-junctionsaswellasallowedthe
discoveryofnewsplice-junctions(Kimetal.,2013;Langmead&Salzberg,2012).
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 18/24Figure 10 Validation of RNA-seq data by qRT-PCR. (A) Ct values for six mRNA transcripts which
were detected in exosomal samples by RNA-seq are shown. (B) Comparison of diVerent expression
values (RPKM; MDA-MB-436/RPKM; MDA-MB-231) detected by RNA-Seq (dark-grey columns) and
qRT-PCR (light-grey columns) for six diVerently expressed genes.
WeobservedalargeproportionofreadsmappedtorRNAregionsinexosomalsamples.
This was surprising given the fact that intact 18S and 28S rRNA peaks were almost
undetectable in exosomal RNA (Fig. 3). This observation suggested that the majority
of exosomal rRNA is fragmented. Exosomal rRNA fragments could be mapped over
entire length of rRNA (Fig. S3). Fragmented 28S and 18S rRNA were major rRNA
species present in exosomes. The reads mapped to 28S and 18S rRNA were distributed
almost equally in exosomal and cellular RNA samples. What is the possible reason for
generation of exosomal rRNA fragments? RNases present in cell culture conditioned
medium are unlikely to contribute to rRNA fragmentation since exosomal membranes
provide protection against RNase attack. Indeed, treatment of the exosomal preparations
with RNase A did not lead to signiﬁcant diVerence between treated and control samples
in RNA size distribution (data not shown). In the study of Skog et al. (2008) RNase
treatment of the glioblastoma exosomes led to a very insigniﬁcant (less than 7%) decrease
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 19/24in RNA suggesting that exosomal RNA is inaccessible for RNase from outside the vesicles.
A possibility exists that the rRNA fragments are generated after secretion by RNases
originatedfromthehostcellsandincorporatedintoexosomevesicles.Alternatively,rRNA
fragments could be generated inside cells prior to their release to exosomes. Another class
of RNA, tRNA is represented in exosomes mainly by its fragments (Nolte-’t Hoen et al.,
2012). The most abundant tRNA hits in exosomal RNA are all located at the 50 end of
maturetRNAs(Nolte-’tHoenetal.,2012).
RegardlessthebiogenesisofrRNAfragments,itisadvisabletoperformrRNAdepletion
step even in the absence of visible rRNA peaks on RNA proﬁles. This procedure would
allow obtaining much higher sequencing depth for other RNA species. Our attempt to
deplete fragmented rRNA with the popular RiboMinusTMEukaryote Kit failed because of
thedesignoftheprobes.Becausetheprobessizeisshort,manyfragmentsofrRNAarenot
targeted.TheuseoflargernumberoflongerprobesisexpectedtoproduceamoreeYcient
way of pulling-down fragmented rRNA. This technical aspect of working with exosomal
RNAsamplesshouldbecertainlyconsideredinthefuturestudies.
AsaresultoflargerRNApresenceinexosomalsamplesweobservedonly2%ofmapped
reads to known transcripts using RefSeq and GENECODE gene models. Moreover, with
RPKM value >1 we observed a large amount of misannotation due to poor coverage of
the reads over transcripts. Therefore, we suggested another approach, namely ﬁltering
genes based on reads coverage over protein coding sequence for mRNA or exons for
non-coding RNA. This procedure allowed us to achieve more than 90% coverage for
protein-coding and non-coding regions which we considered as highly reliable for
functional classiﬁcation. This approach was helpful to reveal highly expressed genes in
exosomeswhichcouldbepotentiallyusedasnoninvasivebreastcancermarkers.
We report that exosomes are carrying mRNAs that are highly expressed in the host
breast cancer cells (Fig. 9). Thus exosomal transcriptomes are representative of their
cells of origin and should provide a platform for detection of tumor speciﬁc markers.
GO analysis revealed that main biological and molecular functions of both cellular
and exosomal transcripts are enriched in proteins involved in ribosome biogenesis,
translational elongation, ribosomal subunit assembly and rRNA processing. What could
be the signiﬁcance of these functions in exosomal transcriptome? Exosome-associated
mRNAs were shown to be translated into proteins by recipient cells (Ratajczak et al.,
2006; Valadi et al., 2007). We hypothesize that upon arrival to the recipient cells exosomal
mRNAs are translated into proteins supporting ribosomal functions to ensure eYcient
translation of other exosomal mRNAs within a cellular compartment where exosome
content is released. Valadi et al. (2007) also described presence of mRNAs for many
ribosomal proteins in exosomes secreted by mouse mast cell line. Interestingly, Graner
et al. (2009) demonstrated the presence of elongation and translation factors in exosomes
derivedfrombraintumor.
Inconclusion,herewedemonstratedfortheﬁrsttimethatfragmentedrRNAisamajor
species of exosomal RNA. Proposed here custom bioinformatics workﬂow allowed us to
reliably detect other, non-ribosomal RNAs under conditions of limited read numbers.
Jenjaroenpun et al. (2013), PeerJ, DOI 10.7717/peerj.201 20/24Classiﬁcation and quantiﬁcation of the RNA-Seq data revealed that exosomal transcripts
are representative of their cells of origin and thus could form basis for detection of tumor
speciﬁc markers. This information can also be used for getting insights in the molecular
underpinnings of biological eVects produced by these microvesicles. Finding that
exosomes bear mRNAs encoding the necessary components to build-on-site ribosomes
providesavaluableinsightintobiologicalfunctionofthesevesicles.
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